GF
George Farmer Scotiabank Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$4B
| $72.16 | $133 |
84%
upside
| Sector Outperform | 1 month ago |
|
2
UroGen Pharma
URGN
$870M
| $18.80 | $47 |
150%
upside
| Sector Outperform | 2 months ago |
|
3
Syndax Pharmaceuticals
SNDX
$1.39B
| $16.19 | $17 |
5%
upside
| Sector Perform | 4 months ago |
|
4
Janux Therapeutics
JANX
$1.44B
| $23.94 | $41 |
71%
upside
| Sector Perform | 6 months ago |
|
5
NewAmsterdam Pharma
NAMS
$2.89B
| $25.66 | $52 |
103%
upside
| Sector Outperform | 6 months ago |
|
6
BioMarin Pharmaceuticals
BMRN
$10.9B
| $56.75 | $80 |
41%
upside
| Sector Perform | 6 months ago |
|
7
Biogen
BIIB
$20.5B
| $139.94 | $224 |
60%
upside
| Sector Outperform | 6 months ago |
|
8
Viking Therapeutics
VKTX
$2.98B
| $26.53 | $102 |
284%
upside
| Sector Outperform | 6 months ago |
|
9
Kura Oncology
KURA
$706M
| $8.13 | $10 |
23%
upside
| Sector Perform | 7 months ago |
|
10
argenx
ARGX
$44.9B
| $733.66 | $715 |
3%
downside
| Sector Outperform | 10 months ago |
|
11
Aura Biosciences
AURA
$399M
| $6.42 | $23 |
258%
upside
| Sector Outperform | 10 months ago |
|
12
Legend Biotech
LEGN
$6.46B
| $34.99 | $76 |
117%
upside
| Sector Outperform | 1 year ago |
|
13
Absci
ABSI
$359M
| $2.40 | $13 |
442%
upside
| Sector Outperform | 1 year ago |
|
14
Moderna
MRNA
$9.45B
| $24.28 | $109 |
349%
upside
| Market Perform | 4 years ago |
|
15
Incyte
INCY
$16.7B
| $85.44 | $87 |
2%
upside
| Market Perform | 4 years ago |
|
|
16
BioMarin Pharmaceuticals
BMRN
$10.9B
| $56.75 | $108 |
90%
upside
| Market Perform | 5 years ago |
|
17
Exelixis
EXEL
$10.1B
| $37.38 | $27 |
28%
downside
| Market Perform | 5 years ago |
|